Comments
Loading...

Tango Therapeutics

TNGXNASDAQ
Logo brought to you by Benzinga Data
$8.18
-0.12-1.45%
After Hours: Sep 20, 5:03 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$19.00
Lowest Price Target1
$13.00
Consensus Price Target1
$15.14

Tango Therapeutics (NASDAQ:TNGX) Stock, Analyst Ratings, Price Targets, Forecasts

Tango Therapeutics Inc has a consensus price target of $15.14 based on the ratings of 8 analysts. The high is $19 issued by Jefferies on July 17, 2024. The low is $13 issued by HC Wainwright & Co. on September 10, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Wedbush, and Jefferies on September 10, 2024, August 8, 2024, and July 17, 2024, respectively. With an average price target of $15 between HC Wainwright & Co., Wedbush, and Jefferies, there's an implied 94.05% upside for Tango Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
2
May
1
Jul
1
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Wedbush
Jefferies
Guggenheim
Barclays

1calculated from analyst ratings

Analyst Ratings for Tango Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Tango Therapeutics (TNGX) stock?

A

The latest price target for Tango Therapeutics (NASDAQ:TNGX) was reported by HC Wainwright & Co. on September 10, 2024. The analyst firm set a price target for $13.00 expecting TNGX to rise to within 12 months (a possible 68.18% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Tango Therapeutics (TNGX)?

A

The latest analyst rating for Tango Therapeutics (NASDAQ:TNGX) was provided by HC Wainwright & Co., and Tango Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Tango Therapeutics (TNGX)?

A

There is no last upgrade for Tango Therapeutics

Q

When was the last downgrade for Tango Therapeutics (TNGX)?

A

There is no last downgrade for Tango Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Tango Therapeutics (TNGX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tango Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tango Therapeutics was filed on September 10, 2024 so you should expect the next rating to be made available sometime around September 10, 2025.

Q

Is the Analyst Rating Tango Therapeutics (TNGX) correct?

A

While ratings are subjective and will change, the latest Tango Therapeutics (TNGX) rating was a reiterated with a price target of $13.00 to $13.00. The current price Tango Therapeutics (TNGX) is trading at is $7.73, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch